Kathleen Goin's most recent trade in Palvella Therapeutics Inc. was a trade of 2,154 Common Stock done at an average price of $7.1 . Disclosure was reported to the exchange on July 15, 2026.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Palvella Therapeutics Inc | Kathleen Goin | Chief Operating Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 7.14 per share. | 15 Jul 2026 | 2,154 | 2,154 | - | 7.1 | 15,380 | Common Stock |
| Palvella Therapeutics Inc | Kathleen Goin | Chief Operating Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Jul 2026 | 2,154 | 6,473 | - | - | Stock Option (Right to Buy) | |
| Palvella Therapeutics Inc | Kathleen Goin | Chief Operating Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Jul 2026 | 2,148 | 6,444 | - | - | Stock Option (Right to Buy) | |
| Palvella Therapeutics Inc | Kathleen Goin | Chief Operating Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 9.08 per share. | 15 Jul 2026 | 2,148 | 4,302 | - | 9.1 | 19,504 | Common Stock |
| Palvella Therapeutics Inc | Kathleen Goin | Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 150.25 per share. | 15 Jul 2026 | 1,911 | 0 | - | 150.3 | 287,133 | Common Stock |
| Palvella Therapeutics Inc | Kathleen Goin | Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 149.27 per share. | 15 Jul 2026 | 1,029 | 1,911 | - | 149.3 | 153,595 | Common Stock |
| Palvella Therapeutics Inc | Kathleen Goin | Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 148.40 per share. | 15 Jul 2026 | 840 | 2,940 | - | 148.4 | 124,658 | Common Stock |
| Palvella Therapeutics Inc | Kathleen Goin | Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 147.14 per share. | 15 Jul 2026 | 522 | 3,780 | - | 147.1 | 76,805 | Common Stock |
| Palvella Therapeutics Inc | Kathleen Goin | Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 110.26 per share. | 17 Jun 2026 | 2,390 | 1,912 | - | 110.3 | 263,520 | Common Stock |
| Palvella Therapeutics Inc | Kathleen Goin | Chief Operating Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 7.14 per share. | 17 Jun 2026 | 2,154 | 2,154 | - | 7.1 | 15,380 | Common Stock |
| Palvella Therapeutics Inc | Kathleen Goin | Chief Operating Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 17 Jun 2026 | 2,154 | 8,627 | - | - | Stock Option (Right to Buy) | |
| Palvella Therapeutics Inc | Kathleen Goin | Chief Operating Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 17 Jun 2026 | 2,148 | 8,592 | - | - | Stock Option (Right to Buy) | |
| Palvella Therapeutics Inc | Kathleen Goin | Chief Operating Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 9.08 per share. | 17 Jun 2026 | 2,148 | 4,302 | - | 9.1 | 19,504 | Common Stock |
| Palvella Therapeutics Inc | Kathleen Goin | Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 111.31 per share. | 17 Jun 2026 | 1,887 | 25 | - | 111.3 | 210,047 | Common Stock |
| Palvella Therapeutics Inc | Kathleen Goin | Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 112.24 per share. | 17 Jun 2026 | 25 | 0 | - | 112.2 | 2,806 | Common Stock |
| Palvella Therapeutics Inc | Kathleen Goin | Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 110.35 per share. | 20 May 2026 | 3,363 | 939 | - | 110.3 | 371,095 | Common Stock |
| Palvella Therapeutics Inc | Kathleen Goin | Chief Operating Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 May 2026 | 2,154 | 10,781 | - | - | Stock Option (Right to Buy) | |
| Palvella Therapeutics Inc | Kathleen Goin | Chief Operating Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 7.14 per share. | 20 May 2026 | 2,154 | 2,154 | - | 7.1 | 15,380 | Common Stock |
| Palvella Therapeutics Inc | Kathleen Goin | Chief Operating Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 9.08 per share. | 20 May 2026 | 2,148 | 4,302 | - | 9.1 | 19,504 | Common Stock |
| Palvella Therapeutics Inc | Kathleen Goin | Chief Operating Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 May 2026 | 2,148 | 10,740 | - | - | Stock Option (Right to Buy) | |
| Palvella Therapeutics Inc | Kathleen Goin | Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 111.30 per share. | 20 May 2026 | 891 | 48 | - | 111.3 | 99,165 | Common Stock |
| Palvella Therapeutics Inc | Kathleen Goin | Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 111.90 per share. | 20 May 2026 | 48 | 0 | - | 111.9 | 5,371 | Common Stock |
| Palvella Therapeutics Inc | Kathleen Goin | Chief Operating Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 7.14 per share. | 15 Apr 2026 | 2,154 | 2,154 | - | 7.1 | 15,380 | Common Stock |
| Palvella Therapeutics Inc | Kathleen Goin | Chief Operating Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Apr 2026 | 2,154 | 12,935 | - | - | Stock Option (Right to Buy) | |
| Palvella Therapeutics Inc | Kathleen Goin | Chief Operating Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Apr 2026 | 2,148 | 12,888 | - | - | Stock Option (Right to Buy) | |
| Palvella Therapeutics Inc | Kathleen Goin | Chief Operating Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 9.08 per share. | 15 Apr 2026 | 2,148 | 4,302 | - | 9.1 | 19,504 | Common Stock |
| Palvella Therapeutics Inc | Kathleen Goin | Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 125.96 per share. | 15 Apr 2026 | 1,502 | 2,800 | - | 126.0 | 189,199 | Common Stock |
| Palvella Therapeutics Inc | Kathleen Goin | Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 127.13 per share. | 15 Apr 2026 | 1,500 | 1,300 | - | 127.1 | 190,688 | Common Stock |
| Palvella Therapeutics Inc | Kathleen Goin | Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 129.17 per share. | 15 Apr 2026 | 639 | 100 | - | 129.2 | 82,539 | Common Stock |
| Palvella Therapeutics Inc | Kathleen Goin | Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 128.24 per share. | 15 Apr 2026 | 561 | 739 | - | 128.2 | 71,940 | Common Stock |
| Palvella Therapeutics Inc | Kathleen Goin | Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 130.33 per share. | 15 Apr 2026 | 100 | 0 | - | 130.3 | 13,033 | Common Stock |
| Palvella Therapeutics Inc | Kathleen Goin | Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 117.56 per share. | 18 Mar 2026 | 2,268 | 2,034 | - | 117.6 | 266,633 | Common Stock |
| Palvella Therapeutics Inc | Kathleen Goin | Chief Operating Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 18 Mar 2026 | 2,154 | 15,089 | - | - | Stock Option (Right to Buy) | |
| Palvella Therapeutics Inc | Kathleen Goin | Chief Operating Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 7.14 per share. | 18 Mar 2026 | 2,154 | 2,154 | - | 7.1 | 15,380 | Common Stock |
| Palvella Therapeutics Inc | Kathleen Goin | Chief Operating Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 18 Mar 2026 | 2,148 | 15,036 | - | - | Stock Option (Right to Buy) | |
| Palvella Therapeutics Inc | Kathleen Goin | Chief Operating Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 9.08 per share. | 18 Mar 2026 | 2,148 | 4,302 | - | 9.1 | 19,504 | Common Stock |
| Palvella Therapeutics Inc | Kathleen Goin | Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 118.37 per share. | 18 Mar 2026 | 1,730 | 304 | - | 118.4 | 204,777 | Common Stock |
| Palvella Therapeutics Inc | Kathleen Goin | Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 119.08 per share. | 18 Mar 2026 | 304 | 0 | - | 119.1 | 36,201 | Common Stock |
| Palvella Therapeutics Inc | Kathleen Goin | Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 79.16 per share. | 18 Feb 2026 | 3,026 | 1,276 | - | 79.2 | 239,529 | Common Stock |
| Palvella Therapeutics Inc | Kathleen Goin | Chief Operating Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 18 Feb 2026 | 2,154 | 17,243 | - | - | Stock Option (Right to Buy) | |
| Palvella Therapeutics Inc | Kathleen Goin | Chief Operating Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 7.14 per share. | 18 Feb 2026 | 2,154 | 2,154 | - | 7.1 | 15,380 | Common Stock |
| Palvella Therapeutics Inc | Kathleen Goin | Chief Operating Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 18 Feb 2026 | 2,148 | 17,184 | - | - | Stock Option (Right to Buy) | |
| Palvella Therapeutics Inc | Kathleen Goin | Chief Operating Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 9.08 per share. | 18 Feb 2026 | 2,148 | 4,302 | - | 9.1 | 19,504 | Common Stock |
| Palvella Therapeutics Inc | Kathleen Goin | Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 79.96 per share. | 18 Feb 2026 | 1,276 | 0 | - | 80.0 | 102,035 | Common Stock |
| Palvella Therapeutics Inc | Kathleen Goin | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Feb 2026 | 48,956 | 48,956 | - | - | Stock Option (Right to Buy) | |
| Palvella Therapeutics Inc | Kathleen Goin | Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 97.94 per share. | 21 Jan 2026 | 3,749 | 0 | - | 97.9 | 367,177 | Common Stock |
| Palvella Therapeutics Inc | Kathleen Goin | Chief Operating Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 7.14 per share. | 21 Jan 2026 | 2,154 | 2,154 | - | 7.1 | 15,380 | Common Stock |
| Palvella Therapeutics Inc | Kathleen Goin | Chief Operating Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 21 Jan 2026 | 2,154 | 19,397 | - | - | Stock Option (Right to Buy) | |
| Palvella Therapeutics Inc | Kathleen Goin | Chief Operating Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 9.08 per share. | 21 Jan 2026 | 2,148 | 4,302 | - | 9.1 | 19,504 | Common Stock |
| Palvella Therapeutics Inc | Kathleen Goin | Chief Operating Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 21 Jan 2026 | 2,148 | 19,332 | - | - | Stock Option (Right to Buy) | |
| Palvella Therapeutics Inc | Kathleen Goin | Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 95.49 per share. | 21 Jan 2026 | 553 | 3,749 | - | 95.5 | 52,806 | Common Stock |
| Palvella Therapeutics Inc | Kathleen Goin | Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 96.47 per share. | 17 Dec 2025 | 4,302 | 0 | - | 96.5 | 415,023 | Common Stock |
| Palvella Therapeutics Inc | Kathleen Goin | Chief Operating Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 17 Dec 2025 | 2,154 | 21,551 | - | - | Stock Option (Right to Buy) | |
| Palvella Therapeutics Inc | Kathleen Goin | Chief Operating Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 7.14 per share. | 17 Dec 2025 | 2,154 | 2,154 | - | 7.1 | 15,380 | Common Stock |
| Palvella Therapeutics Inc | Kathleen Goin | Chief Operating Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 17 Dec 2025 | 2,148 | 21,480 | - | - | Stock Option (Right to Buy) | |
| Palvella Therapeutics Inc | Kathleen Goin | Chief Operating Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 9.08 per share. | 17 Dec 2025 | 2,148 | 4,302 | - | 9.1 | 19,504 | Common Stock |
| Palvella Therapeutics Inc | Kathleen Goin | Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 86.51 per share. | 19 Nov 2025 | 2,802 | 0 | - | 86.5 | 242,388 | Common Stock |
| Palvella Therapeutics Inc | Kathleen Goin | Chief Operating Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 19 Nov 2025 | 2,154 | 23,705 | - | - | Stock Option (Right to Buy) | |
| Palvella Therapeutics Inc | Kathleen Goin | Chief Operating Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 7.14 per share. | 19 Nov 2025 | 2,154 | 2,154 | - | 7.1 | 15,380 | Common Stock |
| Palvella Therapeutics Inc | Kathleen Goin | Chief Operating Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 19 Nov 2025 | 2,148 | 23,628 | - | - | Stock Option (Right to Buy) | |
| Palvella Therapeutics Inc | Kathleen Goin | Chief Operating Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 9.08 per share. | 19 Nov 2025 | 2,148 | 4,302 | - | 9.1 | 19,504 | Common Stock |
| Palvella Therapeutics Inc | Kathleen Goin | Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 85.72 per share. | 19 Nov 2025 | 1,500 | 2,802 | - | 85.7 | 128,577 | Common Stock |
| Palvella Therapeutics Inc | Kathleen Goin | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Feb 2025 | 123,559 | 123,559 | - | - | Non-Qualified Stock Option (right to buy) | |
| Palvella Therapeutics Inc | Kathleen Goin | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Feb 2025 | 5,373 | 5,373 | - | - | Incentive Stock Option (right to buy) | |
| Palvella Therapeutics Inc | Kathleen Goin | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Dec 2024 | 27,843 | 27,843 | - | - | Stock Option (right to buy) |